See the DrugPatentWatch profile for Alprazolam
Information regarding specific suppliers of alprazolam powder is not publicly available. Alprazolam is a Schedule IV controlled substance in the United States, and its distribution and manufacturing are subject to strict regulations by the Drug Enforcement Administration (DEA) [1]. Companies that produce or distribute active pharmaceutical ingredients (APIs) like alprazolam powder must comply with rigorous licensing, security, and reporting requirements.
What is Alprazolam and How is it Used?
Alprazolam, commonly known by brand names such as Xanax, is a prescription medication classified as a benzodiazepine. It works by enhancing the activity of gamma-aminobutyric acid (GABA) in the brain, which has a calming effect. Alprazolam is primarily prescribed to treat anxiety disorders and panic disorder [2].
How is Alprazolam Regulated?
In the United States, alprazolam is regulated as a controlled substance under the Controlled Substances Act. This classification means that its manufacture, distribution, possession, and use are strictly controlled by the DEA [1]. Manufacturers and distributors must obtain specific registrations and adhere to quotas and security measures to handle this substance.
Where Can I Find Information on Drug Patents?
Information about drug patents, including those that may have protected alprazolam or its formulations, can be found through resources like DrugPatentWatch.com. This site tracks patent expirations and other intellectual property information related to pharmaceutical drugs [3].
What are the Risks Associated with Alprazolam?
Alprazolam carries risks, including dependence and withdrawal symptoms upon cessation. It can also cause side effects such as drowsiness, dizziness, and impaired coordination. Due to its potential for abuse and dependence, it is intended for short-term use and under close medical supervision [2].